Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LORAZEPAM Cause Attention deficit/hyperactivity disorder? 7 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Attention deficit/hyperactivity disorder have been filed in association with LORAZEPAM (Lorazepam). This represents 0.0% of all adverse event reports for LORAZEPAM.

7
Reports of Attention deficit/hyperactivity disorder with LORAZEPAM
0.0%
of all LORAZEPAM reports
0
Deaths
6
Hospitalizations

How Dangerous Is Attention deficit/hyperactivity disorder From LORAZEPAM?

Of the 7 reports, 6 (85.7%) required hospitalization.

Is Attention deficit/hyperactivity disorder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LORAZEPAM. However, 7 reports have been filed with the FAERS database.

What Other Side Effects Does LORAZEPAM Cause?

Drug ineffective (3,775) Drug abuse (3,741) Toxicity to various agents (2,836) Completed suicide (2,340) Off label use (2,178) Somnolence (2,114) Sopor (2,042) Anxiety (1,573) Fall (1,524) Overdose (1,516)

What Other Drugs Cause Attention deficit/hyperactivity disorder?

METHYLPHENIDATE (127) VALPROATE (101) AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (88) LAMOTRIGINE (88) SODIUM OXYBATE (85) PAROXETINE (68) FINASTERIDE (65) QUETIAPINE (62) ARIPIPRAZOLE (59) FLUOXETINE (56)

Which LORAZEPAM Alternatives Have Lower Attention deficit/hyperactivity disorder Risk?

LORAZEPAM vs LORCASERIN LORAZEPAM vs LORLATINIB LORAZEPAM vs LORMETAZEPAM LORAZEPAM vs LORNOXICAM LORAZEPAM vs LOSARTAN

Related Pages

LORAZEPAM Full Profile All Attention deficit/hyperactivity disorder Reports All Drugs Causing Attention deficit/hyperactivity disorder LORAZEPAM Demographics